Pancreatic cancer is difficult to detect, in part because the pancreas sits deep in the abdominal cavity in a position that can vary from person to person; pancreatic tumors therefore can remain hidden until too late for treatment.
New MRI method uses altered glucose to 'light up' pancreatic cancer retrieved 24 June 2024 from https://medicalxpress.com/news/2024-06-mri-method-glucose-pancreatic-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jun 21, 2024 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study points to new combination strategy for pancreatic cancerPancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and is projected to become the second-leading cause of cancer-related death by 2030. Although progress has been made in improving outcomes, the five-year survival rate remains stubbornly low at just 13%.
Read more »
An antibacterial protein provides a new therapeutic target against pancreatic cancerImmunotherapy represents a new hope in the fight against cancer; however, not all tumors respond to this treatment. Pancreatic cancer is a type of tumor that does not respond to currently approved drugs and is therefore lethal for 9 out of every 10 people diagnosed.
Read more »
New global research aims to improve survival rates for pancreatic cancer patientsA study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating pancreatic cancer patients with chemotherapy (with or without radiation therapy) before surgery to remove a tumor. The study focuses specifically on pancreatic adenocarcinoma patients.
Read more »
New 3D technique reveals precancerous pancreatic lesionsResearchers at the Johns Hopkins Kimmel Cancer Center's Sol Goldman Pancreatic Cancer Research Center have developed a 3D genomic profiling technique to identify small precancerous lesions in the pancreas—called pancreatic intraepithelial neoplasias (PanINs)—that lead to one of the most aggressive, deadly pancreatic cancers.
Read more »
National working group releases ethical guidance for new portable MRI brain researchMRI has transformed neuroscience research over the past 50 years, but research participants have had to travel to the scanner. With the advent of highly portable magnetic resonance imaging (pMRI), the scanner will now come to them.
Read more »
New eye tracking controlled VR system enhances MRI scans for young childrenNew eye tracking technology has been developed which enables gaze based human computer interaction to operate immediately and robustly without any explicit set-up tasks.
Read more »